{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:31:17Z","timestamp":1793381477069,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Natural Science Foundation of China","award":["82303563"],"award-info":[{"award-number":["82303563"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Science and Technology Program of Guangdong","award":["2023A1515010567"],"award-info":[{"award-number":["2023A1515010567"]}]},{"name":"Science and Technology Program of Guangdong","award":["2021A1515111121"],"award-info":[{"award-number":["2021A1515111121"]}]},{"name":"Medical Scientific Research Foundation of Guangdong Province of China","award":["A2024078"],"award-info":[{"award-number":["A2024078"]}]},{"name":"Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes, Sun-Yat-Sen University","award":["KLB09001"],"award-info":[{"award-number":["KLB09001"]}]},{"name":"the Key Laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology","award":["[2013]163"],"award-info":[{"award-number":["[2013]163"]}]},{"name":"Guangdong Provincial Fund for Distinguished Young Scholars","award":["2021B1515020066"],"award-info":[{"award-number":["2021B1515020066"]}]},{"name":"Guangzhou Science and Technology Project","award":["2023B03J1242"],"award-info":[{"award-number":["2023B03J1242"]}]},{"name":"Guangzhou bureau of basic science grant","award":["202201020576"],"award-info":[{"award-number":["202201020576"]}]},{"name":"111 project","award":["No. B20056"],"award-info":[{"award-number":["No. B20056"]}]},{"name":"Guangzhou Municipal Science and Technology Bureau","award":["201704020131"],"award-info":[{"award-number":["201704020131"]}],"id":[{"id":"https:\/\/ror.org\/0560dtp08","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03577-7","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T05:32:03Z","timestamp":1752816723000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Delivery of an ERK inhibitor using bioactive lipid nanoparticles reduces angiogenesis and prevents oral squamous cell carcinoma development"],"prefix":"10.1186","volume":"23","author":[{"given":"Zixian","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyue","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nvlue","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuepeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wende","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiquan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phei Er","family":"Saw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,18]]},"reference":[{"issue":"1","key":"3577_CR1","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1128\/MMBR.00031-10","volume":"75","author":"M Cargnello","year":"2011","unstructured":"Cargnello M, Roux PP. Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol Mol Biology Reviews: MMBR. 2011;75(1):50\u201383.","journal-title":"Microbiol Mol Biology Reviews: MMBR"},{"key":"3577_CR2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1146\/annurev.cellbio.19.111401.091942","volume":"19","author":"DK Morrison","year":"2003","unstructured":"Morrison DK, Davis RJ. Regulation of MAP kinase signaling modules by scaffold proteins in mammals. Annu Rev Cell Dev Biol. 2003;19:91\u2013118.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"3577_CR3","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.phrs.2018.08.013","volume":"135","author":"R Roskoski Jr","year":"2018","unstructured":"Roskoski R Jr. Targeting oncogenic Raf protein-serine\/threonine kinases in human cancers. Pharmacol Res. 2018;135:239\u201358.","journal-title":"Pharmacol Res"},{"issue":"5","key":"3577_CR4","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374.","journal-title":"Cell"},{"key":"3577_CR5","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.phrs.2019.01.039","volume":"142","author":"R Roskoski Jr","year":"2019","unstructured":"Roskoski R Jr. Targeting ERK1\/2 protein-serine\/threonine kinases in human cancers. Pharmacol Res. 2019;142:151\u201368.","journal-title":"Pharmacol Res"},{"issue":"22","key":"3577_CR6","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1038\/sj.onc.1210422","volume":"26","author":"PJ Roberts","year":"2007","unstructured":"Roberts PJ, Der CJ. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene. 2007;26(22):3291\u2013310.","journal-title":"Oncogene"},{"issue":"12","key":"3577_CR7","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/nrd4281","volume":"13","author":"AA Samatar","year":"2014","unstructured":"Samatar AA, Poulikakos PI. Targeting RAS-ERK signalling in cancer: promises and challenges. Nat Rev Drug Discovery. 2014;13(12):928\u201342.","journal-title":"Nat Rev Drug Discovery"},{"issue":"7","key":"3577_CR8","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1021\/acsmedchemlett.8b00220","volume":"9","author":"SB Boga","year":"2018","unstructured":"Boga SB, Deng Y, Zhu L, Nan Y, Cooper AB, Shipps GW Jr., Doll R, Shih NY, Zhu H, Sun R, et al. MK-8353: discovery of an orally bioavailable dual mechanism ERK inhibitor for oncology. ACS Med Chem Lett. 2018;9(7):761\u20137.","journal-title":"ACS Med Chem Lett"},{"key":"3577_CR9","doi-asserted-by":"crossref","unstructured":"Moschos SJ, Sullivan RJ, Hwu WJ, Ramanathan RK, Adjei AA, Fong PC, Shapira-Frommer R, Tawbi HA, Rubino J, Rush TS. 3rd: Development of MK-8353, an orally administered ERK1\/2 inhibitor, in patients with advanced solid tumors. JCI Insight 2018, 3(4).","DOI":"10.1172\/jci.insight.92352"},{"key":"3577_CR10","doi-asserted-by":"publisher","first-page":"104799","DOI":"10.1016\/j.oraloncology.2020.104799","volume":"107","author":"A Almangush","year":"2020","unstructured":"Almangush A, M\u00e4kitie AA, Triantafyllou A, de Bree R, Strojan P, Rinaldo A, Hernandez-Prera JC, Su\u00e1rez C, Kowalski LP, Ferlito A, et al. Staging and grading of oral squamous cell carcinoma: an update. Oral Oncol. 2020;107:104799.","journal-title":"Oral Oncol"},{"key":"3577_CR11","doi-asserted-by":"crossref","unstructured":"Cheng Y, Chen J, Shi Y, Fang X, Tang Z. MAPK Signaling Pathway in Oral Squamous Cell Carcinoma: Biological Function and Targeted Therapy. Cancers 2022, 14(19).","DOI":"10.3390\/cancers14194625"},{"issue":"3","key":"3577_CR12","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s12032-021-01633-4","volume":"39","author":"S Dey","year":"2022","unstructured":"Dey S, Singh AK, Singh AK, Rawat K, Banerjee J, Agnihotri V, Upadhaya D. Critical pathways of oral squamous cell carcinoma: molecular biomarker and therapeutic intervention. Med Oncol (Northwood Lond Engl). 2022;39(3):30.","journal-title":"Med Oncol (Northwood Lond Engl)"},{"issue":"1","key":"3577_CR13","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13046-023-02630-3","volume":"42","author":"Y Pan","year":"2023","unstructured":"Pan Y, Liu J, Gao Y, Guo Y, Wang C, Liang Z, Wu M, Qian Y, Li Y, Shen J, et al. FBXW7 loss of function promotes esophageal squamous cell carcinoma progression via elevating MAP4 and ERK phosphorylation. J Experimental Clin cancer Research: CR. 2023;42(1):75.","journal-title":"J Experimental Clin cancer Research: CR"},{"issue":"3","key":"3577_CR14","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/s10637-022-01326-3","volume":"41","author":"A Stathis","year":"2023","unstructured":"Stathis A, Tolcher AW, Wang JS, Renouf DJ, Chen LC, Suttner LH, Freshwater T, Webber AL, Nayak T, Siu LL. Results of an open-label phase 1b study of the ERK inhibitor MK-8353 plus the MEK inhibitor selumetinib in patients with advanced or metastatic solid tumors. Investig New Drugs. 2023;41(3):380\u201390.","journal-title":"Investig New Drugs"},{"issue":"4","key":"3577_CR15","first-page":"715","volume":"44","author":"J Majidpoor","year":"2021","unstructured":"Majidpoor J, Mortezaee K. Angiogenesis as a hallmark of solid tumors - clinical perspectives. Cell Oncol (Dordrecht Netherlands). 2021;44(4):715\u201337.","journal-title":"Cell Oncol (Dordrecht Netherlands)"},{"issue":"4","key":"3577_CR16","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s12272-022-01382-6","volume":"45","author":"SH Choi","year":"2022","unstructured":"Choi SH, Yoo SS, Lee SY, Park JY. Anti-angiogenesis revisited: reshaping the treatment landscape of advanced non-small cell lung cancer. Arch Pharm Res. 2022;45(4):263\u201379.","journal-title":"Arch Pharm Res"},{"issue":"9","key":"3577_CR17","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1016\/j.ajpath.2020.05.020","volume":"190","author":"F Roudnicky","year":"2020","unstructured":"Roudnicky F, Poyet C, Buser L, Saba K, Wild P, Otto VI, Detmar M. Characterization of tumor blood vasculature expression of human invasive bladder Cancer by laser capture microdissection and transcriptional profiling. Am J Pathol. 2020;190(9):1960\u201370.","journal-title":"Am J Pathol"},{"key":"3577_CR18","doi-asserted-by":"crossref","unstructured":"Horiguchi H, Kadomatsu T, Oike Y. The two faces of Angiopoietin-Like protein 2 in Cancer. Cancer Sci 2024.","DOI":"10.1111\/cas.16434"},{"key":"3577_CR19","doi-asserted-by":"crossref","unstructured":"Pomella S, Melaiu O, Dri M, Martelli M, Gargari M, Barillari G. Effects of angiogenic factors on the Epithelial-to-Mesenchymal transition and their impact on the onset and progression of oral squamous cell carcinoma: an overview. Cells 2024, 13(15).","DOI":"10.3390\/cells13151294"},{"key":"3577_CR20","doi-asserted-by":"crossref","unstructured":"Fang J, Tan J, Lin L, Cao Y, Xu R, Lin C, He G, Xu X, Xiao X, Jiang Q et al. Bioactive nanotherapeutic ultrasound contrast agent for concurrent breast Cancer ultrasound imaging and treatment. Adv Healthc Mater 2024:e2401436.","DOI":"10.1002\/adhm.202401436"},{"key":"3577_CR21","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.actbio.2022.12.022","volume":"157","author":"S Cao","year":"2023","unstructured":"Cao S, Zhang W, Pan H, Huang Z, Guo M, Zhang L, Xu X, Saw PE. Bioactive lipid-nanoparticles with inherent self-therapeutic and anti-angiogenic properties for cancer therapy. Acta Biomater. 2023;157:500\u201310.","journal-title":"Acta Biomater"},{"issue":"4","key":"3577_CR22","doi-asserted-by":"publisher","first-page":"471","DOI":"10.7150\/ijbs.16290","volume":"13","author":"QQ Zhang","year":"2017","unstructured":"Zhang QQ, Chen J, Zhou DL, Duan YF, Qi CL, Li JC, He XD, Zhang M, Yang YX, Wang L. Dipalmitoylphosphatidic acid inhibits tumor growth in triple-negative breast cancer. Int J Biol Sci. 2017;13(4):471\u20139.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"3577_CR23","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41392-021-00572-w","volume":"6","author":"L Zhong","year":"2021","unstructured":"Zhong L, Li Y, Xiong L, Wang W, Wu M, Yuan T, Yang W, Tian C, Miao Z, Wang T, et al. Small molecules in targeted cancer therapy: advances, challenges, and future perspectives. Signal Transduct Target Therapy. 2021;6(1):201.","journal-title":"Signal Transduct Target Therapy"},{"issue":"6","key":"3577_CR24","doi-asserted-by":"publisher","first-page":"e2001680","DOI":"10.1002\/adhm.202001680","volume":"10","author":"A Brouillard","year":"2021","unstructured":"Brouillard A, Deshpande N, Kulkarni AA. Engineered multifunctional Nano- and biological materials for Cancer immunotherapy. Adv Healthc Mater. 2021;10(6):e2001680.","journal-title":"Adv Healthc Mater"},{"issue":"9","key":"3577_CR25","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.7150\/thno.14882","volume":"6","author":"TY Lin","year":"2016","unstructured":"Lin TY, Guo W, Long Q, Ma A, Liu Q, Zhang H, Huang Y, Chandrasekaran S, Pan C, Lam KS, et al. HSP90 inhibitor encapsulated Photo-Theranostic nanoparticles for synergistic combination Cancer therapy. Theranostics. 2016;6(9):1324\u201335.","journal-title":"Theranostics"},{"issue":"47","key":"3577_CR26","doi-asserted-by":"publisher","first-page":"55790","DOI":"10.1021\/acsami.1c14592","volume":"13","author":"J Gonzalez-Valdivieso","year":"2021","unstructured":"Gonzalez-Valdivieso J, Garcia-Sampedro A, Hall AR, Girotti A, Arias FJ, Pereira SP, Acedo P. Smart nanoparticles as advanced Anti-Akt kinase delivery systems for pancreatic Cancer therapy. ACS Appl Mater Interfaces. 2021;13(47):55790\u2013805.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"2","key":"3577_CR27","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3858\/emm.2009.41.2.012","volume":"41","author":"HJ Choi","year":"2009","unstructured":"Choi HJ, Lee JH, Park SY, Cho JH, Han JS. STAT3 is involved in phosphatidic acid-induced Bcl-2 expression in HeLa cells. Exp Mol Med. 2009;41(2):94\u2013101.","journal-title":"Exp Mol Med"},{"issue":"6","key":"3577_CR28","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1002\/jcb.21260","volume":"101","author":"KJ Oh","year":"2007","unstructured":"Oh KJ, Lee SC, Choi HJ, Oh DY, Kim SC, Min do S, Kim JM, Lee KS, Han JS. Role of phospholipase D2 in anti-apoptotic signaling through increased expressions of Bcl-2 and Bcl-xL. J Cell Biochem. 2007;101(6):1409\u201322.","journal-title":"J Cell Biochem"},{"issue":"9","key":"3577_CR29","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/nrd.2016.278","volume":"16","author":"P Saharinen","year":"2017","unstructured":"Saharinen P, Eklund L, Alitalo K. Therapeutic targeting of the angiopoietin-TIE pathway. Nat Rev Drug Discovery. 2017;16(9):635\u201361.","journal-title":"Nat Rev Drug Discovery"},{"key":"3577_CR30","doi-asserted-by":"publisher","first-page":"7079","DOI":"10.2147\/IJN.S250001","volume":"15","author":"S Badrigilan","year":"2020","unstructured":"Badrigilan S, Heydarpanahi F, Choupani J, Jaymand M, Samadian H, Hoseini-Ghahfarokhi M, Webster TJ, Tayebi L. A review on the biodistribution, pharmacokinetics and toxicity of Bismuth-Based nanomaterials. Int J Nanomed. 2020;15:7079\u201396.","journal-title":"Int J Nanomed"},{"issue":"7","key":"3577_CR31","doi-asserted-by":"publisher","first-page":"746","DOI":"10.7150\/thno.10732","volume":"5","author":"PE Saw","year":"2015","unstructured":"Saw PE, Park J, Lee E, Ahn S, Lee J, Kim H, Kim J, Choi M, Farokhzad OC, Jon S. Effect of PEG pairing on the efficiency of cancer-targeting liposomes. Theranostics. 2015;5(7):746\u201354.","journal-title":"Theranostics"},{"issue":"11","key":"3577_CR32","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.2215\/CJN.02440314","volume":"10","author":"SK Nigam","year":"2015","unstructured":"Nigam SK, Wu W, Bush KT, Hoenig MP, Blantz RC, Bhatnagar V. Handling of drugs, metabolites, and uremic toxins by kidney proximal tubule drug transporters. Clin J Am Soc Nephrology: CJASN. 2015;10(11):2039\u201349.","journal-title":"Clin J Am Soc Nephrology: CJASN"},{"issue":"6","key":"3577_CR33","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/s41581-024-00819-z","volume":"20","author":"Y Huang","year":"2024","unstructured":"Huang Y, Ning X, Ahrari S, Cai Q, Rajora N, Saxena R, Yu M, Zheng J. Physiological principles underlying the kidney targeting of renal nanomedicines. Nat Rev Nephrol. 2024;20(6):354\u201370.","journal-title":"Nat Rev Nephrol"}],"updated-by":[{"DOI":"10.1186\/s12951-026-05182-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:00:00Z","timestamp":1793318400000}}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03577-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03577-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03577-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T16:45:54Z","timestamp":1793378754000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03577-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,18]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3577"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03577-7","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,18]]},"assertion":[{"value":"1 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: fig 6 has been revised.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2026","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12951-026-05182-8","URL":"https:\/\/doi.org\/10.1186\/s12951-026-05182-8","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics and consent to publish declarations","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"524"}}